Ready to play
Ready to play
Reports have indicated that Pfizer expects its sales to reach $100 billion by 2026, after achieving $80 billion in the previous year. This comes amid the company's efforts to strengthen its position in the global pharmaceutical market.
Notice: This Is an AI-Generated Summary
Comments (0)